Brief: Armata Pharma Reports Quarterly Loss Per Share Of $0.49
14/05/2020 22:02
May 14 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2020
RESULTS AND
PROVIDES GENERAL CORPORATE UPDATE
* ARMATA PHARMACEUTICALS INC - WELL CAPITALIZED WITH $24.2
MILLION
OF UNRESTRICTED CASH AND CASH EQUIVALENTS AS OF MARCH 31
* ARMATA PHARMACEUTICALS INC QTRLY LOSS FROM OPERATIONS WAS
$4.9
MILLION AS COMPARED TO $3.4 MILLION
* ARMATA PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.49
Source text for Eikon: ID:nPn8QY0wda
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles